Withholding Treatment

Subscribe to Selected New Research on Withholding Treatment

464 relevant articles (31 outcomes, 21 trials/studies) found for this Therapy

Description: Withholding or withdrawal of a particular treatment or treatments, often (but not necessarily) life-prolonging treatment, from a patient or from a research subject as part of a research protocol. The concept is differentiated from REFUSAL TO TREAT, where the emphasis is on the health professional's or health facility's refusal to treat a patient or group of patients when the patient or the patient's representative requests treatment. Withholding of life-prolonging treatment is usually indexed only with EUTHANASIA, PASSIVE, unless the distinction between withholding and withdrawing treatment, or the issue of withholding palliative rather than curative treatment, is discussed.

Also Known As:

Cessation of Treatment; Withdrawing Treatment; Care, Withdrawing; Treatment Cessation; Treatment Cessations; Treatment, Withdrawing; Treatment, Withholding; Treatments, Withdrawing; Treatments, Withholding; Withdrawing Treatments; Withholding Treatments; Withdrawing Care

Relationship Network

Therapy Context: Research Results

Therapeutics: 5215

Patient Care

Withholding Treatment: 464

Passive Euthanasia: 12

Health Care Facilities, Manpower, and Services

Health Services

Patient Care

Withholding Treatment: 464

Passive Euthanasia: 12

Experts

1.	Han, Sok-Won: 1 article (05/2008)
2.	Choi, Kyu Yong: 1 article (05/2008)
3.	Cho, Young-Seok: 1 article (05/2008)
4.	Son, Hye Suk: 1 article (05/2008)
5.	Park, Yong-Wan: 1 article (05/2008)
6.	Cho, Young Seok: 1 article (05/2008)
7.	Kim, Hyung Keun: 1 article (05/2008)
8.	Han, Sok Won: 1 article (05/2008)
9.	Kim, Jin-Soo: 1 article (05/2008)
10.	Choi, Kyu-Yong: 1 article (05/2008)

Related Diseases

1.	Infection 09/10/1994 - "Four weeks after cessation of treatment the 14C-urea breath test showed that the infection was eradicated in 133 out of 140 patients (95%)" 10/01/2002 - "H.pylori infection was determined in the entry of the study and four weeks after the cessation of treatment by means of histology and CLO-test" 03/10/2007 - "No evidence of relapse of infection was detected at 2 weeks after the cessation of treatment" 02/01/2006 - "pylori infection and side-effects of the treatment regimen were assessed 4 weeks after the cessation of treatment" 05/01/2002 - "In some patients pin site infection developed during the treatment, which resulted in cessation of treatment" Order ALL the reference details at left...
2.	Psoriasis (Pustulosis Palmaris et Plantaris) 04/01/2002 - "There was no evidence of disease rebound or worsening of psoriasis following treatment cessation" 01/01/1977 - "Psoriasis recurred in approximately half of those patients followed for more than 2 months, on average 5 weeks after cessation of treatment" 07/26/2001 - "CONCLUSIONS: Treatment with alefacept for 12 weeks is associated with improvement in chronic plaque psoriasis; some patients have a sustained clinical response after the cessation of treatment" 02/01/2004 - "CONCLUSIONS: Alefacept improved quality of life in patients with chronic plaque psoriasis and maintained this benefit for at least 12 weeks following cessation of treatment" 01/01/2006 - "METHODS: An open-label, multicentre, investigational study was performed in 41 patients with moderate-to-severe plaque psoriasis who had recently completed clinical studies with efalizumab and had developed signs of inflammatory recurrence following abrupt cessation of treatment" Order ALL the reference details at left...
3.	Polyps 09/01/2002 - "The numbers of rectal polyps before and after treatment and approximately one year after cessation of treatment were counted using a flexible colonoscope and compared" 05/01/2008 - "Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]" 04/01/2002 - "Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report." Order ALL the reference details at left...
4.	Hepatitis C 01/01/1998 - "Seventeen patients with actively replicating hepatitis C were consecutively enrolled and treated with IFN alpha 5 MIU three times a week and followed up for at least 6 months after cessation of treatment" 01/01/1990 - "We conclude that a 24-week course of interferon therapy is effective in controlling disease activity in many patients with hepatitis C, although relapse after the cessation of treatment is common." 11/30/1989 - "We conclude that a 24-week course of interferon therapy is effective in controlling disease activity in many patients with hepatitis C, although relapse after the cessation of treatment is common." Order ALL the reference details at left...
5.	Chronic Hepatitis B 12/01/2001 - "CONCLUSIONS: Thymosin is effective in suppressing viral replication in chronic hepatitis B virus infection, but the effect is delayed until 12 months after the cessation of treatment." 02/01/2004 - "AIM: Lamivudine is effective in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, but the relapse rate after cessation of treatment is high" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Interferons
2.	Antigens
3.	alefacept (Amevive)
4.	Buserelin (Suprefact)
5.	Lamivudine (3TC)
6.	Cyclosporine (Ciclosporin)
7.	Antipsychotic Agents (Antipsychotics)
8.	Chloroquine (Aralen)
9.	Metronidazole (Metric)
10.	Hepatitis B e Antigens

Related Therapies and Procedures

1.	Fundoplication
2.	Euthanasia (Mercy Killing)
3.	Drug Therapy (Chemotherapy)
4.	Assisted Suicide (Physician Assisted Suicide)
5.	Nebulizers and Vaporizers (Inhaler)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 13871 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>